3.
BIM多态性与短期疗效的差异
Relationship between BIM gene polymorphism and therapeutic efficacy of tyrosine kinase inhibitor
| BIM | CR | PR | SD | PD | ORR (%) | P |
| CR: complete response; PR: partial response; SD: stable dosease; PD: progressive disease; ORR: objective response rate. | ||||||
| Deletion polymorphism | 0 | 4 | 8 | 2 | 28.57 | 0.557 |
| Non-deletion polymorphism | 1 | 26 | 36 | 5 | 39.71 | |